# Papaverine and Stereotactic Body Radiotherapy (SBRT) for Non Small Cell Lung Cancer (NSCLC) or Lung Metastases

> **NCT03824327** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Ohio State University Comprehensive Cancer Center** · enrollment: 19 (actual)

## Conditions studied

- Lung Non-Small Cell Carcinoma

## Interventions

- **PROCEDURE:** Blood Oxygen Level Dependent Imaging
- **DRUG:** Papaverine Hydrochloride
- **RADIATION:** Stereotactic Body Radiation Therapy

## Key facts

- **NCT ID:** NCT03824327
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-02-07
- **Primary completion:** 2026-08-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03824327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03824327, "Papaverine and Stereotactic Body Radiotherapy (SBRT) for Non Small Cell Lung Cancer (NSCLC) or Lung Metastases". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03824327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*